Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Gains from Investment Securities (2023 - 2025)

CG Oncology filings provide 3 years of Gains from Investment Securities readings, the most recent being -$76000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 101.16% to -$76000.0 in Q4 2025 year-over-year; TTM through Sep 2025 was $3.2 million, a 297.39% increase, with the full-year FY2025 number at $4.1 million, down 37.55% from a year prior.
  • Gains from Investment Securities hit -$76000.0 in Q4 2025 for CG Oncology, down from $3.2 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $6.6 million in Q4 2024 to a low of -$76000.0 in Q4 2025.
  • Median Gains from Investment Securities over the past 3 years was $3.2 million (2025), compared with a mean of $2.9 million.
  • The widest YoY moves for Gains from Investment Securities: up 307696.2% in 2025, down 101.16% in 2025.
  • CG Oncology's Gains from Investment Securities stood at $5.5 million in 2023, then increased by 18.83% to $6.6 million in 2024, then crashed by 101.16% to -$76000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were -$76000.0 (Q4 2025), $3.2 million (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.